Yardimla - PowerPoint PPT Presentation

1 / 74
About This Presentation
Title:

Yardimla

Description:

Yard mla reme teknikleri Son Geli meler Do . Dr. B lent DURAN C. . T p Fak ltesi Kad n Hastal klar ve Do um AD. Tarih e Louise Brown born July 25 ... – PowerPoint PPT presentation

Number of Views:136
Avg rating:3.0/5.0
Slides: 75
Provided by: JimT49
Category:

less

Transcript and Presenter's Notes

Title: Yardimla


1
Yardimla üreme teknikleriSon Gelismeler
  • Doç. Dr. Bülent DURAN
  • C. Ü. Tip Fakültesi Kadin Hastaliklari ve Dogum
    AD.

2
Tarihçe
  • Louise Brown born July 25, 1978
  • First IVF baby worldwide
  • Pioneering work of Robert Edwards and Patrick
    Steptoe, England
  • Elizabeth Carr born December 28, 1981
  • First American IVF baby
  • Drs. Howard and Georgeanna Jones, Norfolk

3
(No Transcript)
4
Ilerlemeler
  • Basari oranlarinin artmasi
  • Çogul gebeliklerin azalmasi
  • Yeni tedaviler
  • Basit tedaviler

5
Raporlandirma1985 1999
  • Raporlandirma basladi. 1985
  • Annual reports published by ASRM (American
    Society of Reproductive Medicine) and its SART
    (Society for Assisted Reproductive Technologies)
  • Voluntary at first, now a requirement of
    membership and federally mandated
  • Reported cycles
  • 647, 208 treatment cycles
  • 155,661 clinical pregnancies
  • 177,745 babies

Fertil Steril 78943-50, 2002.
6
Gebelik oranlari
Clinical Pregnancy / Transfer
Fertil Steril 78943-50, 2002.
7
Daha az çogul gebelik
Triplet delivery rates
Quadruplet delivery rates
Fertil Steril 78943-50, 2002.
8
Çogul gebelik
The major problem in ART pregnancies
9
PREMATURITY n 57 / 247 (23.07 )
10
Kadin yasinin güçlü etkisi
lt35 35-37 38-40 41-42 43
  • Pregnancy rates within each age range continue
    to climb, but.
  • Maternal age still a critical factor in overall
    success, i.e., success very limited when age gt 40
    years.

Fertil Steril 78943-50, 2002.
11
MISCARRIAGE Kadin yasinin etkisi
per cent
40
33.33
33.33
35
30
25
20
15
10
1/3
2/6
5
0
20-24
25-29
30-34
35-39
40-44
12
Yeni tedaviler
  • Sperm problems ICSI (Intracytoplasmic sperm
    injection)
  • Egg problems Donor Egg
  • Uterine problems Gestational carrier
  • Surplus embryos Cryopreservation
  • Genetic problems PGD (Preimplantation genetic
    diagnosis)
  • Clonings Stem
    cell

13
Bioteknoloji nedir ?
  • Biotechnology problemleri çözen ve ürünler
    gelistiren bir dizi bilimsel araçtir.
  • Teknolojinin pek çok alanini kapsar
  • Bazilari mantar hücrelerini yillardir kullanirken
    Genetik testler ise çok yenidir.
  • Klonlama ve stem cell arastirmalari da
    bioteknolojinin diger dallaridir

14
Giris
  • Klonlama basitçe kopyalama demektir
  • Insanlar bu konuyu düsündügünde insanin
    kopyalanmasi ya da klon koyun Dollyi
    animsamaktadirlar
  • Fakat klonlama ile insan ve hayvanlarin tam
    kopyasi disinda da isler yapilmaktadir
  • Bitki, hayvan ve insanlarin herbir hücresi hergün
    arastirma ve uygulama labaratuarlarinda
    kopyalanmaktadir.

15
Klon nedir?
  • Diger bir organizma ile ayni genetik bilgiyi
    tasiyan bir organizmadir.

16
Niçin?
  1. Istenen niteliklerdeki organizmalarin kitlesel
    üretimi
  2. Tehlikesiz veya üstün türlerin çogaltilmasi
  3. Insanlarda organ transplantasyonu için
  4. En çok sevilenin yeniden yasatilmasi
  5. Infertility kendilerinden fertil bir kopya
  6. Yedek parça (Organs, blood, kidneys, etc.)
  7. Vücut parçalarinin üretimi
  8. Eugenics süper insan irkini yaratmak

17
Eugenics
  • Spesifik özellikleri seçerek digerlerini
    yoketmektir.
  • Bilim adamlari tüm hastalik genlerini elimine
    ederek saglikli bir bebegi garanti edebilir.
  • Ama bu etik midir?

18
Embriyo yapmanin 3 yolu"
  1. Sexual reproduction
  2. Cloning or asexual reproduction
  3. Parthenogenesis

19
1. SEXUAL REPRODUCTION
  • In sexual reproduction a child gets half its
    genes from the mother (in her egg) and half from
    its father (in his sperm)

20
2. CLONING OR ASEXUAL REPRODUCTION
  • Cloning üremenin aseksüel bir formudur.
  • Çocugun tüm genleri tek bir bireyin bir vücut
    hücresinden gelir.

21
2. CLONING OR ASEXUAL REPRODUCTION
22
Who is the clonal child's genetic mother or
father?
  • Anladigimiz gibi klonal bir çocugun genetik bir
    anne veya babasi olmayacaktir. Onun sadece tek
    bir nükleer donoru vardir.

23
If a man cloned himself, would the child be that
man's son or his twin brother?
  • Ikisi de degil, biolojik iliskide yeni bir
    kategori olacaktir onun klonu

24
3. PARTHENOGENESIS
25
Klonlamanin tarihçesi
  • 5000 B.C.- Gelecek yilin tahili için tohumlarin
    yetistirilmesi
  • 1952- Tarihte ilk kopyalanan hayvan bir kurbaga
    yavrusudur.
  • 1976- Insan DNA si yeni fertilize bir siçan
    yumurtasina injekte edilerek kismen insan
    özellikleri tasiyan siçanlar üretildi.
  • 1978- Dünyanin ilk tüp bebegi
  • 1987- Embriyonik hücrelerden ilk memeliler
    kopyalandi.
  • 1998- Dolly yöntemiyle Japonlar iki dana
    ürettiklerini bildirdiler.
  • 1998- Hawaii Üniversitesi arastiricilari 50 den
    fazla siçan klonladiklarini bildirdiler.
  • 2000- Ingiltere erken evre insan embriyolarin
    klonlanmasi patentini alan ilk ülke oldu. Geron
    enstitisü klon insanlar yaratma düsünceleri
    olmadigini açikladilar.
  • 2000-Dolly i yaratan grup domuzlari da
    klonladiklarini ilan ettiler. Bilim adamlari
    genetik mühendislikle sekillendirilmis domuzlarin
    insan organlarinin üretilmesi için umutlu
    olduklarini açikladilar.

26
3 tip klonlama vardir.
  • 1) Molecular cloning
  • 2) Cellular cloning
  • 3) Cloning of animal

27
Molecular cloning
  • En basit seviyede moleküler biologlar DNA
    klonlari olustururlar. Genlerin moleküler
    temelini olustururlar
  • DNA fragments containing genes are copied and
    amplified in a host cell, usually a bacterium.
  • The process of molecular cloning allows the
    scientists to produce large quantities of
    identical DNA to be use in many scientific
    experiments.

28
Cellular cloning
  • At the cellular stage, cellular cloning copies
    are made of cells derived from the soma, or body,
    by growing these cells in a laboratory.
  • The genetic makeup of the resulting cloned cells,
    called a cell line, is identical to that of the
    original cell.
  • Since molecular and cellular cloning of this sort
    does not involve germ cells (eggs or sperm), the
    cloned cells are not capable of developing into a
    baby.

29
Cloning of animal
  • This type of cloning aims to reproduce
    genetically identical animals.
  • This level of cloning can typically be divided
    into two distinct processes, 1. Blastomere
    separation and 2. Nuclear transplantation
    cloning.

30
About Dolly
  • On March 24 1999
  • Dolly gave birth to 3 lambs ,2 boys and 1 girl
  • Genetically she was 6 years -old when born.

31
The potential benefits of human cloning
  • Two major benefits to human health
  • 1.Assisted Reproduction
  • 2.Human Organ/Tissue Transplantation

32
Potential Harms and Disadvantages
  • Risks of physical harm to the child born through
    somatic cell nuclear transfer

33
Risks of
  1. hormonal manipulation in the egg donor
  2. multiple miscarriages in the birth mother and
    possibly severe developmental abnormalities in
    any resulting child.
  3.   The possibility of compromising
    individualities.
  4.   Loss of genetic variation.
  5.   A black market of fetuses may arise from
    desirable donors that will want to clone
    themselves, i.e., movie stars, athletes, etc.

34
Risks of
  • 6. Technology is not well developed.
  •  It has a low fertility rate.
  •  In cloning Dolly, 277 eggs were used, 30 started
    to divide, nine induced pregnancy, and only one
    survived to term (Nash).
  • 7.  Clones may be treated as second-class
    citizens.
  • 8.  Unknown psychosocial harms with impacts on
    the family and society.

35
HUMAN GENETIC ENGINEERING
  • Human genetic engineering means changing the
    genes in a living human cell.
  • Suppose you had a lung disease caused by
    defective genes in your lung cells. If there was
    a way to fix those genes, you might be cured.
  • Scientists change the genes in living cells by
    putting the desired "new" gene into a little
    virus-like organism which is allowed to get into
    your cells and which inserts the new gene into
    the cell along with the "old" genes

36
HUMAN GENETIC ENGINEERING
37
Designer Baby
  • Called Designer Baby or the Child of your
    Dreams.
  • This is done by picking up the correct type of
    genes you want the child to have.
  • You can create the appearance of your child and
    design his or her intelligence level.
  • Parents would be able to create a
    high-performance child.
  • Selecting embryo with the right kind of gene to
    be implanted into the mothers womb would also
    enable the child to be free from inheritable
    diseases.

38
PRE-IMPLANTATION GENETIC DIAGNOSIS AND SELECTION
(PDS)
39
What are stem cells?
  • Cells which have the ability to continuously
    divide and develop into various kinds of tissue.
  • Stem cells are primordial cells capable of
    developing into a variety of types of cells.
  • Some stem cells are found in the adult body.
  • Others are found in very early embryos.
  • These stem cells can be cultured in petri dishes
    and potentially used to generate "therapeutic
    tissues" or "spare organs"

40
Cell Types
  1. Somatic these are the normal cells in our body,
    except for our reproductive cells (egg and sperm)
  2. Pluripotent these types of cells can give rise
    to most types of cells in the body, but cannot
    make a human embryo
  3. Totipotent these types of cells have unlimited
    ability.
  4. They can make a human embryo
  5. They can specialize into any kind of cell in the
    body

41
What totipotent cells can do?
42
STEM CELLS
43
STEM CELLS
44
Potential medical benefits from stem cell research
  • Stem cell technology is a new but rapidly
    expanding field.
  • Researchers are hoping that stem cells can be
    used to repair diseased or damaged tissue in
    patients.

45
Potential Benefits
  1. Cancer research cancer cells display abnormal
    cell development. Stem cell research can help us
    understand why cancer cells begin to divide
    uncontrollably.
  2. Birth defects some birth defects occur because
    of abnormal cell division or specialization.
  3. Drug testing new medications could be tested
    using human cells instead of animal, evaluating
    their effectiveness earlier in the process.
  4. Generation of new cells for a wide variety of uses

46
(No Transcript)
47
The sources of stem cells
  • Unused human embryos from in vitro fertilization.
  • 2. Aborted human fetuses

48
(No Transcript)
49
There is a third alternative for stem cells
  • 3. Somatic Cell Nuclear Transfer which is the
    technique used in cloning

50
Different kinds of stem cells
  1. Embryonic stem cells come from embryos (lt6
    weeks).
  2. Stem cells from blastocysts (2 weeks) are
    virtually immortal.
  3. Fetal stem cells come from fetuses (gt 6 weeks)
  4. Stem cells are present in some adult tissues,
    including brain, spinal cord, and bone marrow.

51
Question to consider
  • Is it acceptable to use stem cells from fetuses
    for medical research or treatment?

52
Questions to consider
  • Do we think it is acceptable to use early
    embryos to provide stem cells?
  • Do early embryos have rights?
  • Is it acceptable to create an embryo by cloning
    in order to provide stem cells to be used for
    medical research or treatment?

53
Spare embryos
  • There are many stored embryos in countries where
    infertility treatments are offered,
  • If they are not used they are destroyed or
    allowed to perish.
  • On the other hand, there is a shortage of
    unfertilized eggs available to infertility
    clinics.
  • Researchers prefer using spare embryos.
  • However, this method destroys one embryo to
    create another embryo, which is in turn destroyed
    by the removal of stem cells.

54
Question to consider
  • Is it acceptable to use early embryos remaining
    after fertility treatment, which would otherwise
    perish, to provide stem cells for research?

55
Fetuses from pregnancy terminations
  • Their ability to renew themselves is also more
    limited.
  • If such cells could be multiplied in the
    laboratory, then less foetal tissue would needed
    for treating patients.
  • However, animal studies have shown that it is
    more difficult to produce normal tissues from
    these cells.
  • It is harder to collect stem cells from foetuses
    than from early embryos.

56
Adults
  • Even adults can provide some stem cells, which
    have limited powers of renewal and change.
  • For example, bone marrow cells can produce all
    the different types of blood cells and recent
    research with animals indicates that they may
    also be able to rebuild damaged tissue.

57
Question to consider
  • Is it ethical to delay research using embryonic
    stem cells until it is known whether adult stem
    cells are as useful?

58
Ethical and legal issues surrounding cloning and
stem cell research
  • None of the therapies mentioned can be developed
    without a great deal of research and this depends
    on adequate supplies of stem cells.
  • At present, early embryos are the best source of
    suitable cells.
  • But creating and using early embryos as a source
    of stem cells raises ethical problems.

59
The range of views people have about the status
of the human embryo
  • On the one hand are people who see the early
    embryo as having the same rights to protection as
    they have.
  • On the other hand are those who see the early
    embryo as simply a collection of cells with no
    special rights.
  • There are many shades of opinion between these
    positions.

60
Opposition to Stem cell Research
  • Killing human embryos is unacceptable
  • Embryonic stem cell therapies are not necessary
  • Human embryonic stem cell research encourages
    abortions.
  • The research will increase killing of human
    embryos
  • Embryonic stem cells come from embryos that can
    become adults
  • Embryonic stem cells come from embryos with
    recognizable body parts

61
Current Situation
  • Current laws do not regulate embryo production or
    use by private companies
  • Most human embryonic stem lines belong to private
    companies.

62
Türkiyede durum
  • Üremeye Yardimci Tedavi Merkezleri Yönetmeliginde
    Degisiklik Yapilmasina Dair Yönetmelik Resmi
    Gazete Tarihi 08 Temmuz 2005 Resmi Gazete
    Sayisi 25869

63
Türkiyede durum
  • "Madde 17 Bu Yönetmelik ile gösterilen vasif ve
    sartlarda olmayarak izin belgesi veya ruhsatname
    alinmadan tabipler ve diger sahislar tarafindan
    ÜYTE uygulamak için özel yerler açilmasi veya
    oturduklari yerlerin bir bölümünün bu uygulamaya
    tahsis edilmesi kendilerine ÜYTE uygulanacak
    adaylardan alinan yumurta ve spermler ile elde
    edilen embriyolarin bir baska maksatla veya baska
    adaylarda, aday olmayanlardan alinanlarin da
    adaylarda kullanilmasi ve uygulanmasi ve bu
    Yönetmelikte belirtilenlerin disinda her ne
    maksatla olursa olsun bulundurulmasi,
    kullanilmasi, nakledilmesi, satilmasi yasaktir.
    Bu yasaga ve bu Yönetmelik hükümlerine uymadigi
    tespit edilenlerin faaliyetleri Bakanlikça
    durdurulur.

64
Türkiyede durum
  • Yardimci üreme tekniklerinin uygulandigi
    merkezlerde üçten fazla embriyo transfer
    edilmemesi esastir. Yas faktörü, embriyo kalitesi
    ve benzeri tibbî zorunluluk hallerinde üçten
    fazla embriyo transfer edilmesi durumunda
    uygulamayi yapan tabip gerekçesini belgelendirmek
    zorundadir. Üreme hücreleri ve gonad dokularinin
    saklanmasi yasaktir. Ancak tibbî zorunluluk
    hallerinde üreme hücreleri ve gonad dokulari
    saklanabilir. Saklanan üreme hücreleri ve gonad
    dokulari evlilik disinda ve baska sahislar için
    kullanilamaz. Dondurulan üreme hücreleri ve gonad
    dokulari alinan kisinin istegine göre imha
    edilebilir. Üreme hücreleri ve gonad dokularinin
    saklanmasini gerektiren tibbî zorunluluk
    hallerinin nelerden ibaret oldugu, üreme
    hücreleri ve gonad dokulari saklanmasina iliskin
    diger usül ve esaslar Bakanlikça yayimlanacak
    tebligle belirlenir.

65
Türkiyede durum
  • Adaylardan fazla embriyo alinmasi durumunda
    eslerden her ikisinin rizasi alinarak embriyolar
    dondurulmak suretiyle saklanabilir. Bes yili
    geçmemek sartiyla, merkez tarafindan tespit
    edilecek süre içinde her iki esin rizasi alinarak
    ayni adayda kullanilabilir. Bu süre sonunda veya
    eslerden birinin ölümü veya eslerin birlikte
    talebi veya bosanmanin hükmen sabit olmasi
    halinde, bu süreden önce saklanan embriyolar
    derhal imha edilir. Saklama, kullanma ve imha
    bilgileri Komisyon tarafindan belirlenen
    sürelerde Bakanliga bildirilir. Saklama ve imha
    islemlerinin yapilmasinda Ek 3deki Embriyo
    Saklama Bilgi Fisi ve Embriyo Imha Bilgi Fisi ile
    ÜYTE Uygulanacak Çiftlere Ait Izin Belgesi
    doldurulur."

66
Türkiyede durum
  • Türkiyede oosit donörlügü, sperm bagisi,
    tasiyici annelik yasaktir.
  • Saglik bakanligi embriyonik kök hücre
    çalismalarini yasaklamistir.
  • PGD sadece bazi merkezlerde yapilmaktadir.
  • Saglik Bakanligi embriyo transferlerinde en çok 3
    yasagini getirmistir.

67
Gelisme
Clinical Pregnancy / Transfer
X
Nuclear Transfer
X
Cytoplasmic Transfer
PGD
Hatching
ICSI
Subzonal Insertion
Partial Zona Dissection
X
Co-Culture
ZIFT
GIFT
Donor Egg
Cryopreservation
68
ICSI Erkek faktörünün asilmasi
Fertil Steril 78943-50, 2002.
69
Basit tedaviler
  • Laparoscopic egg retrieval
  • Now transvaginal ultrasound-guided
  • Laparoscopic replacement of eggs / embryos
  • Now transcervical embryo transfer
  • Daily monitoring of response
  • Now every few days during stimulation
  • Intramuscular injections of hormones
  • Now many given subcutaneously

70
US ile Avrupanin karsilastirilmasiIVF, 1998
9.1
10.8
9.8
Fertil Steril 78943-50, 2002.
71
Bildirilen sonuçlarin tarihçesi
Cycles Clinics
CDC system
Wyden law
Voluntary reporting
Fertil Steril 78943-50, 2002.
72
FDA kurallari
  • Advances to date developed without government
    funding, using traditional IRB / informed consent
    process
  • In past year, FDA has asserted authority over ART
    procedures, and has prohibited
  • Cytoplasmic Transfer
  • Nuclear Transfer
  • Embryo Co-Culture
  • Consequences unpredictable, but now have serious
    federal regulations without serious (?any)
    federal support

73
Ilerlemeler
  • Improving success rates
  • Lower rates of multiple
  • pregnancies
  • New therapies
  • Simpler therapies
  • Flexibility of American system
  • Advantage compared to Europe
  • Risk of impeded progress with regulation of
    therapy

Fertil Steril 78943-50, 2002.
74
Tesekkür ederim.
Write a Comment
User Comments (0)
About PowerShow.com